Birmingham, UK and Albuquerque, NM, US (3 June 2024) – Indica Labs and Histofy have come together in a collaboration aimed at bringing Histofy’s cutting-edge AI tools into clinical practice via the established HALO AP® platform.
Histofy and Indica Labs Partner to Introduce AI Solutions to Pathology Practice Read More »
In this blog post, you can learn about some of the new features in the latest release, when to expect your chance to upgrade, and where to find user guides, release notes, and tutorial videos.
HALO®, HALO AI, and HALO Link 4.0 Features and Functionalities Read More »
Albuquerque, NM – 23 May 2024 – Indica Labs, the global leader in AI-powered digital pathology solutions, announced today the release of the transformative new version of its industry-leading life sciences software.
Albuquerque, NM, and Hamamatsu City, Japan – 22 May, 2024 – Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform.
27 June 2024 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform focused on Indica Labs’ pretrained and untrained AI nuclear and membrane segmentation models.
25 June 2024 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform focused on highly multiplexed immunofluorescence slides.
Albuquerque, NM – 8 May 2024 – Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.
Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform Read More »
13 June 2024 | Join us for this 1-hour webinar to see a live demonstration of HALO AP Dx, the 510k-cleared digital pathology platform from Indica Labs.
Introducing HALO AP Dx: An Enterprise Pathology Platform for Primary Diagnosis Read More »
30 May 2024 | Histologic evaluation of the mucosal changes associated with celiac disease is important for establishing an accurate diagnosis and monitoring the impact of investigational therapies.
Pathologist-Trained Machine Learning Classifiers Quantitate Celiac Disease Features Read More »
Albuquerque, NM, and Los Angeles, CA – 5 April 2024 – Indica Labs, a leading provider of AI-powered digital pathology solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, announce a new partnership to co-market compatibility between MI’s patented HCR™ Imaging technology and Indica’s HALO® software.
